8:25:23
rmacology
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
and the nursing
bank
process
pharmacology
9th editionand
58 the
chapters
8:25:23
nursing
linda
PM11/1/2026test
process
lane lilley
9th edition
shelly
bankrainforth
58pharmacology
chapters
collins
linda
julie
and
lane
s the
snyder11/1/2026,
lilley
nursing
shellyprocess
rainforth
8:25:16
9th
collins
edition
PM11/1/2026,
julie58s chapters
snyder.pdf11/1/2026(f
8:25:13
linda lane
PM11/1/2026,
lilley shelly8:r
TEST BANK PHARMACOLOGY AND THE NURSING PROCESS
10TH EDITION 58 CHAPTERS LINDA LANE LILLEY SHELLY
RAINFORTH COLLINS, JULIE S. SYNDER WITH MULTIPLE
CHOICE ANSWERS
ALL ANSWERED CORRECTLY latest update 2024/2025
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
1. During an intravenous (IV) infusion of amphotericin B, a patient develops tingling
and numbnessin his toes and fingers. What will the nurse do first?
a. Discontinue the infusion immediately.
b. Reduce the infusion rate gradually until the adverse effects
subside.
c. Administer the medication by rapid IV infusion to reduce
these effects.
d. Nothing; these are expected side effects of this medication.
ANS: A
Once the intravenous infusion of amphotericin B has begun, vital signs must be
monitored frequently to assess for adverse reactions such as cardiac dysrhythmias,
visual disturbances, paresthesias (numbness or tingling of the hands or feet),
respiratory difficulty, pain, fever, chills,and nausea. If these adverse effects or a
severe reaction occur, the infusion must be discontinued(while the patient is
closely monitored) and the prescriber contacted. The other options are incorrect.
DIF: COGNITIVE LEVEL: Applying
(Application)TOP: NURSING
PROCESS: Implementation
?
8:25:23
lilley shelly
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
rainforth collins
bank
julie
pharmacology
s snyder11/1/2026,
and the8:25:23
8:25:16
nursingPM11/1/2026test
PM11/1/2026,
process 9th edition
8:25:13
bank
58PM11/1/2026,
pharmacology
chapters linda8:25:23
and
lanethe
lilley
PM11/1/2026test
nursing
shellyprocess
rainforth9th
bank
collins
edition
pharmacology
julie58s chapters
snyder.pdf11/1/2026(f
andlinda
the lane
nursing
lilleyprocess
shelly r
,8:25:23
rmacology
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
and the nursing
bank
process
pharmacology
9th editionand
58 the
chapters
8:25:23
nursing
linda
PM11/1/2026test
process
lane lilley
9th edition
shelly
bankrainforth
58pharmacology
chapters
collins
linda
julie
and
lane
s the
snyder11/1/2026,
lilley
nursing
shellyprocess
rainforth
8:25:16
9th
collins
edition
PM11/1/2026,
julie58s chapters
snyder.pdf11/1/2026(f
8:25:13
linda lane
PM11/1/2026,
lilley shelly8:r
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
The nurse is writing a nursing diagnosis for a plan of care for a patient who
has been newlydiagnosed with type 2 diabetes. Which statement reflects the
correct format for a nursing diagnosis?
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by
statements
such as “I’m upset about having to test my blood sugars.”
d. Anxiety related to new drug therapy, as evidenced by statements
such as“I’m
upset about having to test my blood sugars.”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is
missing the
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety
related to new drug therapy” is missing the “as evidenced by” portion of defining
characteristics. The statementbeginning “Anxiety related to anxious feelings” is
incorrect because the “related to” section is simply a restatement of the problem
“anxiety,” not a separate factor related to the response.
DIF: COGNITIVE LEVEL: Understanding
?
8:25:23
lilley shelly
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
rainforth collins
bank
julie
pharmacology
s snyder11/1/2026,
and the8:25:23
8:25:16
nursingPM11/1/2026test
PM11/1/2026,
process 9th edition
8:25:13
bank
58PM11/1/2026,
pharmacology
chapters linda8:25:23
and
lanethe
lilley
PM11/1/2026test
nursing
shellyprocess
rainforth9th
bank
collins
edition
pharmacology
julie58s chapters
snyder.pdf11/1/2026(f
andlinda
the lane
nursing
lilleyprocess
shelly r
,8:25:23
rmacology
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
and the nursing
bank
process
pharmacology
9th editionand
58 the
chapters
8:25:23
nursing
linda
PM11/1/2026test
process
lane lilley
9th edition
shelly
bankrainforth
58pharmacology
chapters
collins
linda
julie
and
lane
s the
snyder11/1/2026,
lilley
nursing
shellyprocess
rainforth
8:25:16
9th
collins
edition
PM11/1/2026,
julie58s chapters
snyder.pdf11/1/2026(f
8:25:13
linda lane
PM11/1/2026,
lilley shelly8:r
(Comprehension)TOP: NURSING PROCESS:
Nursing Diagnosis
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse
was busy andgave the medication 2 hours after the scheduled dose was due. What
type of problem does this represent?
a. “Right time”
b. “Right dose”
c. “Right route”
d. “Right
medication”
ANS: A
“Right time” is correct because the medication was given more than 30
minutes after the scheduled dose was due. “Dose” is incorrect because the
dose is not related to the time the
medication administration is scheduled. “Route” is incorrect because the route
is not affected.“Medication” is incorrect because the medication ordered will
not change.
DIF: COGNITIVE LEVEL: Applying
(Application)TOP: NURSING
PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
3. The nurse has been monitoring the patient’s progress on a new drug regimen
since the first doseand documenting the patient’s therapeutic response to the
?
8:25:23
lilley shelly
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
rainforth collins
bank
julie
pharmacology
s snyder11/1/2026,
and the8:25:23
8:25:16
nursingPM11/1/2026test
PM11/1/2026,
process 9th edition
8:25:13
bank
58PM11/1/2026,
pharmacology
chapters linda8:25:23
and
lanethe
lilley
PM11/1/2026test
nursing
shellyprocess
rainforth9th
bank
collins
edition
pharmacology
julie58s chapters
snyder.pdf11/1/2026(f
andlinda
the lane
nursing
lilleyprocess
shelly r
,8:25:23
rmacology
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
and the nursing
bank
process
pharmacology
9th editionand
58 the
chapters
8:25:23
nursing
linda
PM11/1/2026test
process
lane lilley
9th edition
shelly
bankrainforth
58pharmacology
chapters
collins
linda
julie
and
lane
s the
snyder11/1/2026,
lilley
nursing
shellyprocess
rainforth
8:25:16
9th
collins
edition
PM11/1/2026,
julie58s chapters
snyder.pdf11/1/2026(f
8:25:13
linda lane
PM11/1/2026,
lilley shelly8:r
medication. Which phase of the nursing processed these actions illustrate?
a. Nursing
diagnosis
b. Planning
c. Implementatio
n
d. Evaluation
ANS: D
Monitoring the patient’s progress, including the patient’s response to the
medication, is part of the evaluation phase. Planning, implementation, and nursing
diagnosis are not illustrated by thisexample.
DIF: COGNITIVE LEVEL: Understanding
(Comprehension)TOP: NURSING PROCESS:
Evaluation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
4. The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes
mellitus. Whichstatement best illustrates an outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient will adhere to the new insulin treatment regimen.
d. The patient will demonstrate correct blood glucose
testingtechnique.
ANS: D
?
8:25:23
lilley shelly
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
rainforth collins
bank
julie
pharmacology
s snyder11/1/2026,
and the8:25:23
8:25:16
nursingPM11/1/2026test
PM11/1/2026,
process 9th edition
8:25:13
bank
58PM11/1/2026,
pharmacology
chapters linda8:25:23
and
lanethe
lilley
PM11/1/2026test
nursing
shellyprocess
rainforth9th
bank
collins
edition
pharmacology
julie58s chapters
snyder.pdf11/1/2026(f
andlinda
the lane
nursing
lilleyprocess
shelly r
rmacology
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
and the nursing
bank
process
pharmacology
9th editionand
58 the
chapters
8:25:23
nursing
linda
PM11/1/2026test
process
lane lilley
9th edition
shelly
bankrainforth
58pharmacology
chapters
collins
linda
julie
and
lane
s the
snyder11/1/2026,
lilley
nursing
shellyprocess
rainforth
8:25:16
9th
collins
edition
PM11/1/2026,
julie58s chapters
snyder.pdf11/1/2026(f
8:25:13
linda lane
PM11/1/2026,
lilley shelly8:r
TEST BANK PHARMACOLOGY AND THE NURSING PROCESS
10TH EDITION 58 CHAPTERS LINDA LANE LILLEY SHELLY
RAINFORTH COLLINS, JULIE S. SYNDER WITH MULTIPLE
CHOICE ANSWERS
ALL ANSWERED CORRECTLY latest update 2024/2025
Chapter 01: The Nursing Process and Drug Therapy
MULTIPLE CHOICE
1. During an intravenous (IV) infusion of amphotericin B, a patient develops tingling
and numbnessin his toes and fingers. What will the nurse do first?
a. Discontinue the infusion immediately.
b. Reduce the infusion rate gradually until the adverse effects
subside.
c. Administer the medication by rapid IV infusion to reduce
these effects.
d. Nothing; these are expected side effects of this medication.
ANS: A
Once the intravenous infusion of amphotericin B has begun, vital signs must be
monitored frequently to assess for adverse reactions such as cardiac dysrhythmias,
visual disturbances, paresthesias (numbness or tingling of the hands or feet),
respiratory difficulty, pain, fever, chills,and nausea. If these adverse effects or a
severe reaction occur, the infusion must be discontinued(while the patient is
closely monitored) and the prescriber contacted. The other options are incorrect.
DIF: COGNITIVE LEVEL: Applying
(Application)TOP: NURSING
PROCESS: Implementation
?
8:25:23
lilley shelly
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
rainforth collins
bank
julie
pharmacology
s snyder11/1/2026,
and the8:25:23
8:25:16
nursingPM11/1/2026test
PM11/1/2026,
process 9th edition
8:25:13
bank
58PM11/1/2026,
pharmacology
chapters linda8:25:23
and
lanethe
lilley
PM11/1/2026test
nursing
shellyprocess
rainforth9th
bank
collins
edition
pharmacology
julie58s chapters
snyder.pdf11/1/2026(f
andlinda
the lane
nursing
lilleyprocess
shelly r
,8:25:23
rmacology
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
and the nursing
bank
process
pharmacology
9th editionand
58 the
chapters
8:25:23
nursing
linda
PM11/1/2026test
process
lane lilley
9th edition
shelly
bankrainforth
58pharmacology
chapters
collins
linda
julie
and
lane
s the
snyder11/1/2026,
lilley
nursing
shellyprocess
rainforth
8:25:16
9th
collins
edition
PM11/1/2026,
julie58s chapters
snyder.pdf11/1/2026(f
8:25:13
linda lane
PM11/1/2026,
lilley shelly8:r
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
The nurse is writing a nursing diagnosis for a plan of care for a patient who
has been newlydiagnosed with type 2 diabetes. Which statement reflects the
correct format for a nursing diagnosis?
a. Anxiety
b. Anxiety related to new drug therapy
c. Anxiety related to anxious feelings about drug therapy, as evidenced by
statements
such as “I’m upset about having to test my blood sugars.”
d. Anxiety related to new drug therapy, as evidenced by statements
such as“I’m
upset about having to test my blood sugars.”
ANS: D
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” is
missing the
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety
related to new drug therapy” is missing the “as evidenced by” portion of defining
characteristics. The statementbeginning “Anxiety related to anxious feelings” is
incorrect because the “related to” section is simply a restatement of the problem
“anxiety,” not a separate factor related to the response.
DIF: COGNITIVE LEVEL: Understanding
?
8:25:23
lilley shelly
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
rainforth collins
bank
julie
pharmacology
s snyder11/1/2026,
and the8:25:23
8:25:16
nursingPM11/1/2026test
PM11/1/2026,
process 9th edition
8:25:13
bank
58PM11/1/2026,
pharmacology
chapters linda8:25:23
and
lanethe
lilley
PM11/1/2026test
nursing
shellyprocess
rainforth9th
bank
collins
edition
pharmacology
julie58s chapters
snyder.pdf11/1/2026(f
andlinda
the lane
nursing
lilleyprocess
shelly r
,8:25:23
rmacology
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
and the nursing
bank
process
pharmacology
9th editionand
58 the
chapters
8:25:23
nursing
linda
PM11/1/2026test
process
lane lilley
9th edition
shelly
bankrainforth
58pharmacology
chapters
collins
linda
julie
and
lane
s the
snyder11/1/2026,
lilley
nursing
shellyprocess
rainforth
8:25:16
9th
collins
edition
PM11/1/2026,
julie58s chapters
snyder.pdf11/1/2026(f
8:25:13
linda lane
PM11/1/2026,
lilley shelly8:r
(Comprehension)TOP: NURSING PROCESS:
Nursing Diagnosis
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the nurse
was busy andgave the medication 2 hours after the scheduled dose was due. What
type of problem does this represent?
a. “Right time”
b. “Right dose”
c. “Right route”
d. “Right
medication”
ANS: A
“Right time” is correct because the medication was given more than 30
minutes after the scheduled dose was due. “Dose” is incorrect because the
dose is not related to the time the
medication administration is scheduled. “Route” is incorrect because the route
is not affected.“Medication” is incorrect because the medication ordered will
not change.
DIF: COGNITIVE LEVEL: Applying
(Application)TOP: NURSING
PROCESS: Implementation
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
3. The nurse has been monitoring the patient’s progress on a new drug regimen
since the first doseand documenting the patient’s therapeutic response to the
?
8:25:23
lilley shelly
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
rainforth collins
bank
julie
pharmacology
s snyder11/1/2026,
and the8:25:23
8:25:16
nursingPM11/1/2026test
PM11/1/2026,
process 9th edition
8:25:13
bank
58PM11/1/2026,
pharmacology
chapters linda8:25:23
and
lanethe
lilley
PM11/1/2026test
nursing
shellyprocess
rainforth9th
bank
collins
edition
pharmacology
julie58s chapters
snyder.pdf11/1/2026(f
andlinda
the lane
nursing
lilleyprocess
shelly r
,8:25:23
rmacology
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
and the nursing
bank
process
pharmacology
9th editionand
58 the
chapters
8:25:23
nursing
linda
PM11/1/2026test
process
lane lilley
9th edition
shelly
bankrainforth
58pharmacology
chapters
collins
linda
julie
and
lane
s the
snyder11/1/2026,
lilley
nursing
shellyprocess
rainforth
8:25:16
9th
collins
edition
PM11/1/2026,
julie58s chapters
snyder.pdf11/1/2026(f
8:25:13
linda lane
PM11/1/2026,
lilley shelly8:r
medication. Which phase of the nursing processed these actions illustrate?
a. Nursing
diagnosis
b. Planning
c. Implementatio
n
d. Evaluation
ANS: D
Monitoring the patient’s progress, including the patient’s response to the
medication, is part of the evaluation phase. Planning, implementation, and nursing
diagnosis are not illustrated by thisexample.
DIF: COGNITIVE LEVEL: Understanding
(Comprehension)TOP: NURSING PROCESS:
Evaluation
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
4. The nurse is assigned to a patient who is newly diagnosed with type 1 diabetes
mellitus. Whichstatement best illustrates an outcome criterion for this patient?
a. The patient will follow instructions.
b. The patient will not experience complications.
c. The patient will adhere to the new insulin treatment regimen.
d. The patient will demonstrate correct blood glucose
testingtechnique.
ANS: D
?
8:25:23
lilley shelly
PM11/1/2026test
https://www.stuvia.com///@@@11/1/2026,
rainforth collins
bank
julie
pharmacology
s snyder11/1/2026,
and the8:25:23
8:25:16
nursingPM11/1/2026test
PM11/1/2026,
process 9th edition
8:25:13
bank
58PM11/1/2026,
pharmacology
chapters linda8:25:23
and
lanethe
lilley
PM11/1/2026test
nursing
shellyprocess
rainforth9th
bank
collins
edition
pharmacology
julie58s chapters
snyder.pdf11/1/2026(f
andlinda
the lane
nursing
lilleyprocess
shelly r